Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Adipose Tissue and Serum Inflammation in GH Deficiency

Recruiting

Conditions: Growth Hormone Deficiency

Interventions: Drug: Growth Hormone

First Posted Date: 2018-04-18

Last Posted Date: 2024-05-06

Lead Sponsor: Columbia University

Target Recruit Count: 60

Registration Number: NCT03500913

Locations: 🇺🇸
Neuroendocrine Unit and Pituitary Center, Columbia University Irving Medical Center, New York, New York, United States

Longitudinal Study of Neurogenetic Disorders

Recruiting

Conditions: Hypotonia
Intellectual Disability
Developmental Delay
Autism Spectrum Disorder
Seizures
Neurodevelopmental Disorders
Hypertonia, Muscle

First Posted Date: 2018-04-10

Last Posted Date: 2024-10-28

Lead Sponsor: Columbia University

Target Recruit Count: 1000

Registration Number: NCT03492060

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Neural Predictors of Social Emotion Regulation Training

Not Applicable

Completed

Conditions: Emotions
Rumination

Interventions: Behavioral: Self regulation
Behavioral: Social regulation

First Posted Date: 2018-04-03

Last Posted Date: 2020-01-23

Lead Sponsor: Columbia University

Target Recruit Count: 62

Registration Number: NCT03487081

Locations: 🇺🇸
Columbia University, New York, New York, United States

Implementing Hypertension Screening Guidelines in Primary Care

Not Applicable

Conditions: White Coat Hypertension
Hypertension,Essential

Interventions: Behavioral: Multifaceted Implementation Strategy

First Posted Date: 2018-03-29

Last Posted Date: 2022-03-22

Lead Sponsor: Columbia University

Target Recruit Count: 2000

Registration Number: NCT03480217

Locations: 🇺🇸
Center for Behavioral Cardiovascular Health, New York, New York, United States

Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis

Phase 4

Terminated

Conditions: Ankylosing Spondylitis
Axial Spondyloarthritis

Interventions: Drug: Meloxicam
Drug: Indomethacin
Drug: Diclofenac
Drug: Celecoxib

First Posted Date: 2018-03-22

Last Posted Date: 2020-09-22

Lead Sponsor: Columbia University

Target Recruit Count: 9

Registration Number: NCT03473665

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Nutritional Status in Children With ALL in Guatemala

Completed

Conditions: Acute Lymphoblastic Leukemia

First Posted Date: 2018-03-20

Last Posted Date: 2024-05-29

Lead Sponsor: Columbia University

Target Recruit Count: 109

Registration Number: NCT03471416

Locations: 🇬🇹
Unidad Nacional de Oncología Pediátrica (UNOP), Guatemala City, Guatemala

Decision Support for BRCA Testing in Ethnically Diverse Women

Not Applicable

Completed

Conditions: Breast Cancer
BRCA1 Mutation
Ovarian Cancer
BRCA2 Mutation

Interventions: Other: iNYP
Other: RealRisks
Other: BNAV
Other: Standard Educational Material
Other: High-Risk Message

First Posted Date: 2018-03-20

Last Posted Date: 2021-04-19

Lead Sponsor: Columbia University

Target Recruit Count: 276

Registration Number: NCT03470402

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy

Phase 3

Completed

Conditions: Cerebral Palsy

Interventions: Drug: Dysport Injectable Product

First Posted Date: 2018-03-19

Last Posted Date: 2022-06-01

Lead Sponsor: Columbia University

Target Recruit Count: 12

Registration Number: NCT03469999

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

PK of Piperacillin/Tazobactam in Adults Undergoing ECMO

Recruiting

Conditions: Acute Respiratory Failure With Hypoxia

First Posted Date: 2018-03-16

Last Posted Date: 2024-02-09

Lead Sponsor: Columbia University

Target Recruit Count: 10

Registration Number: NCT03467854

Locations: 🇺🇸
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York, New York, United States

Novel Adenosine-independent Index of Coronary Artery Stenosis Severity Resting Flow Reserve

Not Applicable

Terminated

Conditions: Coronary; Ischemic

Interventions: Device: Volcano Verrata Pressure Wire
Device: St. Jude Medical (SJM) Aeris Pressure Wire System

First Posted Date: 2018-03-12

Last Posted Date: 2020-02-07

Lead Sponsor: Columbia University

Target Recruit Count: 5

Registration Number: NCT03461705

Locations: 🇺🇸
Columbia University, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy